Walgreens Teams Up with Workflow Services and Exact Sciences to Expand Colorectal Cancer Screening Options
ByAinvest
Friday, Mar 13, 2026 12:51 am ET1min read
EXAS--
Walgreens has partnered with Exact Sciences and Workflow Services to increase colorectal cancer screening awareness and accessibility. The program provides a streamlined pathway for eligible patients to request the Cologuard test, a non-invasive stool DNA test for colorectal cancer screening. The initiative aims to close the screening gap and support earlier detection of colorectal cancer, which is the #1 cause of cancer death in adults under 50 in the US. The Cologuard test is FDA-approved, covered by most insurance companies, and requires no special diet, prep, or time away from work.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet